As we near the end of 2020 and closer to a COVID-19 vaccine, business leaders are starting to looking ahead. As companies begin to rebuild, they’ll face a daunting decision: choosing whom they’ll rebuild with.
As we near the end of 2020 and closer to a COVID-19 vaccine, business leaders are starting to looking ahead. As companies begin to rebuild, they’ll face a daunting decision: choosing whom they’ll rebuild with.